Venusil XBP(L)
XBP (L) C18 has an identical bonded phase as XBP C18. However, XBP (L) C18 has relatively low surface area which allows compounds to have shorter retention times. These columns are an excellent alternative to Hypersil BDS-C18, Hypersil BDS-C8; Zorbax XDB-C18, Zorbax XDB-C8 which comparitively could have too much retention. XBP (L) C18 have relatively larger pore size (150Å) and are suitable for the separation of large molecules.
Ordering Info
Surface: 200m2/g ,Pore size:150 Å |
Type | Dimemsion(mm) | Particle(µm) | Venusil XBP(L) C18 | Venusil XBP(L) C18 | Venusil XBP(L) Silica |
Analytica | 2.1×30 | 5 | VX950302-L | VX850302-L | VSi950302-L |
Analytica | 2.1×50 | 5 | VX950502-L | VX850502-L | VSi950502-L |
Analytica | 2.1×100 | 5 | VX951002-L | VX851002-L | VSi951002-L |
Analytica | 2.1×150 | 5 | VX951502-L | VX851502-L | VSi951502-L |
Analytica | 4.6×50 | 5 | VX950505-L | VX850505-L | VSi950505-L |
Analytica | 4.6×100 | 5 | VX951005-L | VX851005-L | VSi951005-L |
Analytica | 4.6×150 | 5 | VX951505-L | VX851505-L | VSi951505-L |
Analytica | 4.6×250 | 5 | VX952505-L | VX852505-L | VSi952505 |
Applications
Purification Applications---Coicis Oil
European Pharmacopoeia--- Clindamycini Hydrochloride
European Pharmacopoeia---Glibenclamide
European Pharmacopoeia---Bezafibratum
European Pharmacopoeia---Lovastatin
European Pharmacopoeia--- Mometasone furoate
Risperidone HPLC Method developed on Venusil XBP-L
Determination of Five Aglycons in rhubarb by Venusil XBP-C18-L HPLC
bio-equip.cn
Bonna-Agela Technologies Inc. is a separation technology company that serves chemists and biochemists in the field of drug discovery, food analysis, drug testing, environmental analysis and chemical research. We offer a full line of products designed to meet your separation and purification needs from bulk separation media to chromatography columns and SPE cartridges. Through continuing innovation, Agela Technologies Inc. offers customers the best tools and solutions for separation, purification, and analysis of organic and bioorganic compounds.
Through our unique nano-surface modification technology, we have developed Venusil HPLC columns and Cleanert solid phase extraction media having incredibly improved surface properties (e.g., less tailing, higher recovery and larger sample capacity).
Bonna-Agela Technologies Inc. conducts business in North America, Asia and Europe. We sell our products to end users, distributors, and OEM partners. Because of our unique business structure and superior production process, we are able to provide products of the highest quality at very competitive prices. We are also very proud of our full support for customers‘ applications, and we are willing to customize our products to meet any specific requirement of our customers. We are here to assist you in choosing the most appropriate technique and products for your separation needs. Our expertise in separation and unmatchable business flexibility make us a very favorable source of collaboration for many customers in hopes to meet their specific needs.
Bonna-Agela Technologies Inc. has an uncompromised quality policy. All of our products is guaranteed for customers‘ satisfaction.
We are satisfied only if you are!
Bonna-Agela Technologies Inc
2038A Telegraph Rd.
Wilmington, DE 19808, USA
TAL: (302) 438 8798
FAX: (302) 636 9339
E-mail: info@bonnaagela.com
Bonna-Agela India Pvt. Ltd
2ND FLOOR , G-212
SECTOR-63
NOIDA-201301
PH: 0120-4225466-71
FAX: 0120-4225465
E-mail: sales@bonnaagela.com
Bonna-Agela Australia
Unit 6/165 waldron rd, chester hill, NSW, Australia
TEL: 0061(02)82062600
FAX: 0061(02)80039841
E-mail: sales@vetiver.com.au
Jay :sales@vetiver.com.au , Mobile: 0061425868999
Bonna-Agela China
179 South Street, Teda West Zone, Tianjin 300462, China
Tel: +86(22)25321032/7023
Fax: +86(22)25321033
中文
